# Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease

> **NCT06012500** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 78 (actual)

## Conditions studied

- ILD

## Interventions

- **DRUG:** Xenon-129

## Key facts

- **NCT ID:** NCT06012500
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-04-14
- **Primary completion:** 2026-12-01
- **Final completion:** 2027-12-30
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2026-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06012500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06012500, "Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06012500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*